Menu

CDC Director Takes a $165,300 Pay Cut

Robert Redfield’s record-setting salary was nearly double that of his predecessors.

May 9, 2018
Diana Kwon

WIKIMEDIA, JAVERT2113

Robert Redfield, the new director for the Centers for Disease Control and Prevention (CDC), has agreed to have his controversial $375,000 salary reduced to $209,700, Caitlin B. Oakley, a spokesperson for the Department of Health and Human Services (HHS), told reporters yesterday (May 8).

“Dr. Redfield did not want his compensation to become a distraction from the important work of the C.D.C. and asked that his salary be reduced,” Oakley said, according to The New York Times. “Dr. Redfield is being paid in accordance with the formula used to pay the prior three C.D.C. directors.”

According to the Times, Redfield’s initial pay was granted through Title 42, a provision that allows HHS to offer salaries higher than the approved government rates to scientists who possess exceptional qualities.

After being assigned the role of director in March, Redfield was granted a salary that was almost double that of his predecessors. According to The Washington Post, the last two directors, Brenda Fitzgerald and Thomas Frieden, received $193,700 and $219,700, respectively.

Redfield’s initial salary “is an exceptional amount of money for what we’ve seen in the past for (CDC) directors,” Angela Beck, a University of Michigan researcher who studies public health workforce issues, told the Associated Press in April.

On April 26, shortly after news reports revealed Redfield’s salary, Senator Patty Murray (D-Wash) penned a letter to HHS Secretary Alex Azar inquiring why Redfield was receiving significantly higher pay than his predecessors, other public health officials, and his boss. “It is difficult to understand why someone with limited public health experience, particularly in a leadership role, is being disproportionately compensated for his work as compared to other accomplished scientists and public health leaders in comparable roles within the federal government,” she wrote.

A few days later, HHS stated that Redfield was pushing to have his salary reduced.

See “AIDS Researcher Emerges as Top Candidate to Head CDC

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimized metabolic disease drug development

DefiniGEN Ltd are pleased to announce the commercial licensing of CRISPR-Cas9 gene-editing technology from Broad Institute of MIT and Harvard in the USA, to develop human cell disease models to support preclinical metabolic disease therapeutic programmes.